Lorenzo Lolli's Avatar

Lorenzo Lolli

@lorenzololli.bsky.social

Lead Researcher at Aspire Academy | Research Fellow at Manchester Metropolitan University | Views are my own

134 Followers  |  219 Following  |  75 Posts  |  Joined: 29.08.2024  |  2.3266

Latest posts by lorenzololli.bsky.social on Bluesky


No more endless academic paper searches!

Writing a research paper used to take weeks. With tlooto AI, you can go from a rough idea to a structure draft -- in just 3 minutes.

No more endless academic paper searches! Writing a research paper used to take weeks. With tlooto AI, you can go from a rough idea to a structure draft -- in just 3 minutes.

"With [some AI bullshit] you can go from a rough idea to a structured draft โ€” in just 3 minutes"

We're so cooked.

05.08.2025 01:04 โ€” ๐Ÿ‘ 163    ๐Ÿ” 24    ๐Ÿ’ฌ 21    ๐Ÿ“Œ 4

"[T]he scientific enterprise is now witness to widespread, organized defection from the scientific public goods game. Large swaths of players, among them many scientists, reviewers, editors and publishers, are choosing to no longer make genuine contributions to the pot."

05.08.2025 07:22 โ€” ๐Ÿ‘ 22    ๐Ÿ” 12    ๐Ÿ’ฌ 2    ๐Ÿ“Œ 0

Fantastic new paper by @reeserichardson.bsky.social et al.

An enormous amount of work showing the extent of coordinated scientific fraud and involvement of some editors.
The number of fraudulent publications grows at a rate far outpacing that of legitimate science.
www.pnas.org/doi/10.1073/...

04.08.2025 21:27 โ€” ๐Ÿ‘ 107    ๐Ÿ” 45    ๐Ÿ’ฌ 3    ๐Ÿ“Œ 4

โ€œAs the investigation proceeded, it became clear that ๐™– ๐™—๐™ง๐™ค๐™–๐™™ ๐™–๐™ฃ๐™™ ๐™จ๐™ค๐™ฅ๐™๐™ž๐™จ๐™ฉ๐™ž๐™˜๐™–๐™ฉ๐™š๐™™ ๐™ฃ๐™š๐™ฉ๐™ฌ๐™ค๐™ง๐™  of about 35 authors ๐™ฌ๐™š๐™ง๐™š ๐™ฅ๐™ค๐™ฉ๐™š๐™ฃ๐™ฉ๐™ž๐™–๐™ก๐™ก๐™ฎ ๐™˜๐™ค๐™ก๐™ก๐™ช๐™™๐™ž๐™ฃ๐™œ over a very large number of journals and published papers, a fraction of which were published by Frontiers,โ€ @retractionwatch.com

29.07.2025 12:21 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Preview
Frontiers to retract 122 articles, links thousands in other publishersโ€™ journals to โ€œunethicalโ€ network The publisher Frontiers has begun retracting a batch of 122 articles across five journals after an investigation found a network of authors and editors engaged in โ€œunethical actionsโ€ such as manipuโ€ฆ

Frontiers to retract 122 articles, links thousands in other publishersโ€™ journals to โ€œunethicalโ€ network

29.07.2025 10:34 โ€” ๐Ÿ‘ 41    ๐Ÿ” 22    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 4
Preview
Journals Operating Predatory Practices Are Systematically Eroding the Science Ethos: A Gate and Code Strategy to Minimise Their Operating Space and Restore Research Best Practice Scientific research seeks to extend knowledge and understanding, an activity that perhaps more than any other advances society and humanity. In essence, it is the search for truth. But, because it se....

hereโ€™s a positive suggestion for academic publishing.
Journals need to be accredited as meeting integrity standards in order to qualify for APCs
enviromicro-journals.onlinelibrary.wiley.com/doi/full/10....

27.07.2025 07:45 โ€” ๐Ÿ‘ 51    ๐Ÿ” 17    ๐Ÿ’ฌ 2    ๐Ÿ“Œ 2

It seems like a lot of systematic-reviews/meta-analyses are analogous to money laundering. You run a load of studies that nobody actually reads, many of them "dirty", through some process. On the other end you get "clean" results that the ignorant or deceitful can easily communicate as "evidence".

23.07.2025 10:14 โ€” ๐Ÿ‘ 176    ๐Ÿ” 36    ๐Ÿ’ฌ 13    ๐Ÿ“Œ 5

Even @robcaliff.bsky.social says "real world" data is only at the "promise" stage. The only thing it seems to be "missing" is accuracy, completeness, and the ability to account for bias. Their words not mine! ๐Ÿ˜œ www.nejm.org/doi/full/10....

ht @emilymoin.com

24.07.2025 05:14 โ€” ๐Ÿ‘ 27    ๐Ÿ” 9    ๐Ÿ’ฌ 3    ๐Ÿ“Œ 0
Cover picture with blog title & subtitle, and results graph in the background

Cover picture with blog title & subtitle, and results graph in the background

Post just up: Is multiple imputation making up information?

tldr: no.

Includes a cheeky simulation study to demonstrate the point.
open.substack.com/pub/tpmorris...

23.07.2025 15:29 โ€” ๐Ÿ‘ 38    ๐Ÿ” 11    ๐Ÿ’ฌ 3    ๐Ÿ“Œ 0
Trouble at t' (review) mill: How MDPI lets down authors I guess many readers will have had peer reviews where the reviewer doesn't appear to have understood, or even properly read, the paper they...

New blogpost. The shitshow that results when a publisher fails to check up on their peer reviewers, with authors caught up in a nightmare process. deevybee.blogspot.com/2025/07/trou...

21.07.2025 08:45 โ€” ๐Ÿ‘ 70    ๐Ÿ” 38    ๐Ÿ’ฌ 7    ๐Ÿ“Œ 7
External validation, impact assessment and clinical utilization of clinical prediction models: a prospective cohort study We aimed to assess paths taken by clinical prediction models (CPM) after development by quantifying external validation, impact assessment, and utilization in clinical practice.

Our team quantified how often clinical prediction models are evaluated or used. Spoiler alert: we found more self-reported clinical use in patient care than evidence of thorough evaluation.

www.jclinepi.com/article/S089...

18.07.2025 08:19 โ€” ๐Ÿ‘ 6    ๐Ÿ” 3    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

Excellent review discussing different issues plaguing also sports and exercise sciences with unjustified categorisation of continuous measurements and the โ€œblanketโ€ linear mixed-effects modelling on log-transformed values by default compared to more appropriate methods

www.jstor.org/stable/2991772

16.07.2025 16:37 โ€” ๐Ÿ‘ 1    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Preview
A brief guide to statistical analysis of grouped data in preclinical research Nature Metabolism - Clustering and nesting (C&N) arise in many preclinical studies, such as when animals are group-housed or share litters, or in cell culture. Ignoring C&N...

A brief guide to statistical analysis of grouped data in preclinical research rdcu.be/er3HG

21.06.2025 19:22 โ€” ๐Ÿ‘ 14    ๐Ÿ” 6    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Post image

This variable was measured 5 times within each period. There's a person by time interaction in each period โ€“ even the control periods! Probably, serial effects in the repeated measurements are masquerading as individual differences in the outcome over the treatment period. This is not HTE.

15.07.2025 13:36 โ€” ๐Ÿ‘ 1    ๐Ÿ” 1    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 0
Post image

We can look at our replicate crossover trials (a type of n-of-1 trial), some having repeated measurements within each period, to explore this question. We can take a variable for which there was little evidence of HTE. Between-treatment consistency is poor with no person by treatment interaction.

15.07.2025 13:36 โ€” ๐Ÿ‘ 1    ๐Ÿ” 1    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 0

The question was whether repeated measurements WITHIN a single treatment period is compatible with repeated administration of treatment-control cycles โ€“ as in sets of n-of-1 trials โ€“ for informing heterogeneity of treatment effects (HTE). We think not.

15.07.2025 13:36 โ€” ๐Ÿ‘ 2    ๐Ÿ” 1    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 0
OSF

During the peer-review of our paper, โ€œUnderstanding treatment response heterogeneity using randomised crossover trials: A primer for exercise and nutrition scientistsโ€, an interesting question arose which @lorenzololli.bsky.social & I are now pursuing as our next project. osf.io/preprints/os...

15.07.2025 13:36 โ€” ๐Ÿ‘ 3    ๐Ÿ” 1    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 0
Preview
Statistics Notes: Units of analysis In clinical studies the focus of interest is almost always the patient. If we carry out a randomised trial to compare two treatments we are interested in comparing the outcomes of patients who receive...

Essentially, a re-conceptualisation of what should be โ€œthe unit of analysisโ€ compared to blokes like Bland and Altman who seemingly got it wrong all along, aside from highlighting further the robustness and prognostic value of the ๐’”๐’‘๐’๐’“๐’•๐’๐’Ž๐’Š๐’„๐’” from their original study ๐Ÿ˜€

www.bmj.com/content/314/...

15.07.2025 12:23 โ€” ๐Ÿ‘ 1    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

That reply was also excellent for highlighting their โ€œโ€ฆpredictive model was developed based on 894 observations derived from distributed lag models created from 14,500 daily observations spanning 2 seasons. Therefore, the effective sample size is 894, rather than being limited to just 24 playersโ€.

15.07.2025 12:21 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 0

Our field brought -omics to a whole new level by forging novel โ€œ๐’”๐’‘๐’๐’“๐’•๐’๐’Ž๐’Š๐’„๐’”โ€ to bridge โ€œthe gap between ๐’‘๐’†๐’“๐’”๐’๐’๐’‚๐’๐’Š๐’›๐’†๐’… ๐’Ž๐’†๐’…๐’Š๐’„๐’Š๐’๐’† and daily clinical practiceโ€ฆโ€ ๐Ÿ‘€

journals.humankinetics.com/view/journal...

15.07.2025 12:17 โ€” ๐Ÿ‘ 2    ๐Ÿ” 0    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 0
The leaky pipe of clinical prediction models. by @maartenvsmeden.bsky.socialโ€ฌ et al

The leaky pipe of clinical prediction models. by @maartenvsmeden.bsky.socialโ€ฌ et al

You can have all the omni-omics data in the world and the bestest algorithms, but eventually a predicted probability is produced & it should be evaluated using well-established methods, and correctly implemented in the context of medical decision making.

statsepi.substack.com/i/140315566/...

14.07.2025 09:49 โ€” ๐Ÿ‘ 38    ๐Ÿ” 14    ๐Ÿ’ฌ 4    ๐Ÿ“Œ 0
Preview
Quality of scientific papers questioned as academics โ€˜overwhelmedโ€™ by the millions published Widespread mockery of AI-generated rat with giant penis in one paper brings problem to public attention

โ€œVolume is a bad driver,โ€ [Sir Mark Walport] said. โ€œThe incentive should be quality, not quantity. Itโ€™s about re-engineering the system in a way that encourages good research from beginning to end.โ€

www.theguardian.com/science/2025...

13.07.2025 15:31 โ€” ๐Ÿ‘ 30    ๐Ÿ” 12    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 4
OSF

Thanks to @lorenzololli.bsky.social here is the accepted (in IJSNEM) version of our paper, "Understanding treatment response heterogeneity using randomised crossover trials: A primer for exercise and nutrition scientists". This is prior to the proofing stage: osf.io/preprints/os...

11.07.2025 09:31 โ€” ๐Ÿ‘ 3    ๐Ÿ” 2    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

The only problem is that the citations go to papers that don't actually exist.

07.07.2025 06:45 โ€” ๐Ÿ‘ 521    ๐Ÿ” 74    ๐Ÿ’ฌ 17    ๐Ÿ“Œ 8
Preview
Carry-over Carry-on Treatment time During the time I worked in the pharmaceutical industry, I designed and analysed many cross-over trials. The simplest such trial would compare two treatments A & B (say) by allocating p...

Balaam's design. How it works and why you shouldn't use it.
www.linkedin.com/pulse/carry-...

05.07.2025 23:23 โ€” ๐Ÿ‘ 5    ๐Ÿ” 1    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

It's not just about "faulty" data or privacy concerns. It's about whether the information conveyed by the device can help improve decision making in a manner that leads to better outcomes. We have ways of evaluating this, but they are largely ignored, in both academia and industry.

03.07.2025 10:41 โ€” ๐Ÿ‘ 46    ๐Ÿ” 6    ๐Ÿ’ฌ 5    ๐Ÿ“Œ 2

It is baffling how many do not understand that simulation is just a (usually inferior) way of doing the calculations. It is not a way of producing evidence.

01.07.2025 09:20 โ€” ๐Ÿ‘ 4    ๐Ÿ” 2    ๐Ÿ’ฌ 2    ๐Ÿ“Œ 0

We are not going to "sell" the public on the value of universities and higher education by aping how industry promotes itself.

02.07.2025 05:46 โ€” ๐Ÿ‘ 28    ๐Ÿ” 3    ๐Ÿ’ฌ 2    ๐Ÿ“Œ 0
Preview
Springer Nature book on machine learning is full of made-up citations Would you pay $169 for an introductory ebook on machine learning with citations that appear to be made up? If not, you might want to pass on purchasing Mastering Machine Learning: From Basics to Adโ€ฆ

Of course it is:

Springer Nature book on machine learning is full of made-up citations retractionwatch.com/2025/06/30/s...

01.07.2025 04:45 โ€” ๐Ÿ‘ 331    ๐Ÿ” 167    ๐Ÿ’ฌ 11    ๐Ÿ“Œ 31
Preview
Some Practical Guidelines for Effective Sample Size Determination Sample size determination is often an important step in planning a statistical studyโ€”and it is usually a difficult one. Among the important hurdles to be surpassed, one must obtain an estimate of o...

โ€œOne cannot avoid addressing the issues of effect-size elicitation (๐™ž๐™ฃ ๐™–๐™—๐™จ๐™ค๐™ก๐™ช๐™ฉ๐™š ๐™ฉ๐™š๐™ง๐™ข๐™จ) and estimating the error variance, as difficult as these may be.

๐™Ž๐™ฉ๐™–๐™ฃ๐™™๐™–๐™ง๐™™๐™ž๐™ฏ๐™š๐™™ ๐™š๐™›๐™›๐™š๐™˜๐™ฉ๐™จ ๐™™๐™ค ๐™ฃ๐™ค๐™ฉ ๐™ฉ๐™ง๐™–๐™ฃ๐™จ๐™ก๐™–๐™ฉ๐™š ๐™ž๐™ฃ๐™ฉ๐™ค ๐™๐™ค๐™ฃ๐™š๐™จ๐™ฉ ๐™จ๐™ฉ๐™–๐™ฉ๐™š๐™ข๐™š๐™ฃ๐™ฉ๐™จ ๐™–๐™—๐™ค๐™ช๐™ฉ ๐™จ๐™ฉ๐™ช๐™™๐™ฎ ๐™œ๐™ค๐™–๐™ก๐™จ.โ€

www.tandfonline.com/doi/abs/10.1...

30.06.2025 12:43 โ€” ๐Ÿ‘ 1    ๐Ÿ” 1    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

@lorenzololli is following 20 prominent accounts